Trial of New Hernia Repair Technique
Trial Summary
What is the purpose of this trial?
The goal of this trial is to assess whether pre-surgical use of the investigation drug, AGN-151607-DP, can enable less invasive hernia repair.
Why do researchers think this study treatment might be promising for ventral hernia?
The investigation drug, AGN-151607-DP, is injected into the muscles near the hernia before surgery to relax them. Researchers believe that making the tissue more pliable will give surgeons a better chance of repairing the hernia without resorting to more invasive techniques like component separation.
Eligibility Criteria
Adults diagnosed with the condition who meet health and safety criteria may be eligible.Timeline
Screening
Participants are evaluated to confirm eligibility
Treatment
Participants receive the investigation drug and undergo surgery for their hernia.
Follow-up
Participants are monitored for safety
Hernia Recurrence Follow-up
Phone calls to monitor for hernia recurrence
Who Is Running the Clinical Trial?
AbbVie
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.